PMC10156441_01
Upper gastrointestinal series showing oblong stomach and impaired pyloric transit (image taken 13 minutes after contrast instillation, age 15 years).
10-1055-s-0043-57040-i2022080682cr-1.jpg
PMC10156441_01_10-1055-s-0043-57040-i2022080682cr-1.jpg
FI2022080682cr-1
Moreover, transit through the pylorus appeared to take a longer than average time, and the valve itself showed signs of mucosal thickening ( Fig. 1 ).
Endoscopic photographs of the pylorus at first esophagogastroduodenoscopy (EGD) (left) and at control EGD following all dilation sessions (right) (age 15 years).
10-1055-s-0043-57040-i2022080682cr-2.jpg
PMC10156441_01_10-1055-s-0043-57040-i2022080682cr-2.jpg
FI2022080682cr-2
A final endoscopic control was performed 2 months and a half after the first discharge ( Fig. 2 ): no anomalies were found with a patent (if slightly rigid) pylorus, and biopsies taken found only minimal signs of aspecific gastric and duodenal chronic inflammation.